[1] COLOMBO A, PROIETTI R, CULIC V, et al. Triggers of acute myocardial infarction:a neglected piece of the puzzle[J]. J Cardiovasc Med (Hagerstown), 2014, 15(1):1-7. [2] GIDDAY J M, GASCHE Y G, COPIN J C, et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia[J]. Am J Physiol Heart Circ Physiol, 2005, 289(2):H558-H568. [3] RICHTER V C, COELHO M, ARANTES E DE C, et al. Health status and mental health in patients after percutaneous coronary intervention[J]. Rev Bras Enferm, 2015, 68(4):589-595, 676-682. [4] 杨波,杨树森.血栓抽吸与替罗非班在急诊冠状动脉介入慢血流/无复流中的作用[J].中国循证心血管医学杂志,2017,9(11):1406-1408. [5] DE LUCA G, SURYAPRANATA H, STONE G W, et al. Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction:a meta-analysis of randomized trials[J]. Am Heart J, 2007, 153(3):343-353. [6] GALASSO G, SCHIEKOFER S, D'ANNA C, et al. No-reflow phenomenon:pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives[J]. Angiology, 2014, 65(3):180-189. [7] HUANG F C, KUO H C, HUANG Y H, et al. Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy:implication for the treatment of Kawasaki disease[J]. BMC Pharmacol Toxicol, 2017, 18(1):3. [8] LIU HH, ZHANG SS, LIU CR, et al. Resveratrol ameliorates microcystin-LR-induced testis germ cell apoptosis in rats via SIRT1 signaling pathway activation[J]. Toxins(Basel), 2018, 10(6):E235. [9] CHOI S E, KWON S, SEOK S, et al. Obesity-linked phosphorylation of SIRT1 by casein kinase 2 inhibits its nuclear localization and promotes fatty live[J]. Mol Cell Biol, 2017, 37(15):e00006-e00017. [10] FAJAR J K, HERIANSYAH T, ROHMAN M S. The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction:A meta-analysis[J]. Indian Heart J, 2018,70(Suppl3):S406-S418. [11] QUISI A, ALICI G. The relationship between serum rheumatoid factor level and no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. J Clin Lab Anal, 2018, 32(9):e22598. [12] CELIK T, BALTA S, DEMIR M, et al. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Cardiol J, 2016, 23(1):84-92. [13] RANE S, HE M Z, SAYED D, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes[J]. Circ Res, 2009, 104(7):879-886. [14] YANG Y, DUAN W, LI Y, et al. Novel role of silent information regulator 1 in myocardial ischemia[J]. Circulation, 2013, 128(20):2232-2240. [15] TOPOL E J, YADAV J S. Recognition of the importance of embolization in atherosclerotic vascular disease[J]. Circulation, 2000, 101(5):570-580. [16] 刘朝晖, 李德才, 刘思泰, 等. 急性心肌梗死冠状动脉介入术后无复流现象影响因素分析[J]. 临床误诊误治, 2019,32(3):85-89. [17] 潘华福, 叶少武.急性心肌梗死患者经皮冠脉介入术中无复流的研究进展[J].心血管病学进展,2018,39(6):1029-1034. [18] 汤克虎, 任尽平, 张波涛,等.前列地尔对ST段抬高型急性心肌梗死患者经皮冠状动脉介入治疗术中心肌微循环障碍的影响[J].感染、炎症、修复,2018,19(3):164-169. [19] 孙伟伦. 前列地尔注射液对大鼠心肌缺血再灌注后无复流的保护作用和潜在机制[D].长春:吉林大学, 2014. [20] COZZI E, HAZARIKA S, STALLINGS H WRD, et al. Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice[J]. Am J Physiol-Heart Circ Physiol, 2006, 291(2):H894-H903. [21] XU Z B, ALLOUSH J, BECK E, et al. A murine model of myocardial ischemia-reperfusion injury through ligation of the left anterior descending artery[J]. J Vis Exp, 2014(86):e51329- e513336. [22] 韦星, 张冯迪, 阳玉中, 等. 大鼠心肌缺血再灌注损伤后无复流模型的制备[J]. 中国动脉硬化杂志, 2017, 25(7):728-731. [23] 付雯雯. 基于SIRT1信号通路的人参皂苷Rb2和Rg2预处理对心肌损伤的保护作用及机制研究[D]. 长春:吉林大学, 2017. [24] 王蕾. 西洋参与制西洋参对大鼠心肌缺血再灌注损伤保护作用的对比研究[D]. 长春:吉林大学, 2017. [25] 骆秉铨. 冠状动脉无复流现象的临床研究进展[J]. 中国微循环, 2002,6(5):261-264. [26] ITO H. No-reflow phenomenon and prognosis in patients with acute myocardial infarction[J]. Nat Clin Pract Cardiovasc Med, 2006, 3(9):499-506. |